Studies based on pre-diagnostic CRP levels have shown that other (BMI, IL-6 in healthy but not overweight men, leukocytes, metabolic syndrome components) or multiple etiologies of chronic inflammation correlate with increased prostate cancer risk, but often not CRP individually [20,21,26]. This evidence concerns the gene IL6 and metabolic syndrome.